1Tipples GA, Ma MM, Fischer KP, et al. Mutation in HBV RNA dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology, 1996, 24: 714-717. 被引量：1
2Allen MI, Deslauriers M, Andrews CW, et al. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group. Hepatology,1998, 27: 1670-1677. 被引量：1
3Jardi R, Buti M, Rodriguez-Frias F, et al. Rapid detection of lamivudine-resistant hepatitis B virus polymerase gene variants. J Virol Methods, 1999, 83: 181-187. 被引量：1
4Whalley SA, Brown D, Teo CG, et al. Monitoring the emergence of hepatitis B virus polymerase gene variants during lamivudine therapy using the LightCycler. J Clin Microbiol, 2001, 39:1456-1459. 被引量：1
6PfeifeRK,PelzeRC,Coleman P,et al. Early detection of hepatitis B surface antigen-prototype of a new fully automated HBsAg microparticle enzyme immunoassay[J].Clin.Lab.2003, 49:161-166. 被引量：1
7Funk M L,Rosenberg D M, Lok A S.Word-wide epidemiology of HbeAg-negative chronic hepatitis B and associated precore and core promoteRvariants[J].J Viral Hepat,2002,9:52-56. 被引量：1
8Valentine-Thon E.Quality control in nucleic acid testing-where do we stand[J].Clin Virol,2002,25(Suppl 3):13-21. 被引量：1
9Schutten M.Niesters HG.Clinical utility of viral quantification as a tool foRdisease monitoring[J].Expert Rev Mol Diagn,2001,1:153-162. 被引量：1
10Niesters H G.MoleculaRand diagnostic clinical virology in real time[J].Clin Microbiol Infect,2004,10:5-11. 被引量：1
